Major features of the inherited bone marrow failure syndromes.1
Feature . | Fanconi anemia . | Dyskeratosis congenita . | Diamond-Blackfan anemia . | Shwachman-Diamond syndrome . | Severe congenital neutropenia2 . | Amegakaryocytic thrombocytopenia . | Thrombocytopenia absent radii . |
---|---|---|---|---|---|---|---|
Abbreviations: AR, autosomal recessive; XLR, X-linked recessive; AD, autosomal dominant; MDS, myelodysplastic syndrome; HNSCC, head and neck squamous cell carcinoma; Gyn, gynecological. | |||||||
?, data not available or unclear. Cancer means leukemia or solid tumor, probability assuming no other adverse event occurs. | |||||||
1Data derived from cases reported in the literature. | |||||||
2Rosenberg et al5 | |||||||
3Age at hematologic diagnosis in most cases, except in SCN, where it is the age of starting treatment with granulocyte colony-stimulating factor (G-CSF). | |||||||
4Physical findings are outlined in Table 2. | |||||||
5Kaplan-Meier survival analysis, censored at death. | |||||||
6Genes are described in Table 3. | |||||||
~N Lit Cases | >1850 | 425 | 825 | 500 | 374 | 100 | 280 |
Male:Female | 1.2:1 | 4:1 | 1.1:1 | 1.5:1 | 1.2 | 0.8:1 | 0.7:1 |
Age at diagnosis, median (range)3 | 6.6 (0–49) | 15 (0–75) | 0.25 (0–64) | 1 (0–41) | 3 (0–70)2 | 0.1 (0–11) | 0–0.6 |
% diagnosed ≥16 y of age2 | 9 | 46 | 1 | 5 | 132 | 0 | 0 |
Physical findings4 | Yes | Yes | Yes | Yes | No | No | Yes |
Usual hematology | Pancytopenia | Pancytopenia | Anemia | Neutropenia | Neutropenia | Thrombocytopenia | Thrombocytopenia |
Aplastic anemia | Yes | Yes | Rare | Yes | No | Yes | No |
Screening test | Chromosome breakage | Telomere length | Adenosine deaminase | Pancreatic insufficiency | Promyelocyte arrest | Absent/abnormal megakaryocytes | Absent megakaryocytes |
Leukemia or MDS | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Solid tumors | HNSCC, Gyn, brain | HNSCC | Osteosarcoma | No | No | No | No |
Age at cancer, median (range) | 15 (0.1–48) | 28 (1.5–68) | 23 (1.2–44) | 18 (2–43) | 14 (2–26) | 12 (1.6–17) | 5.3 (0–67) |
Cumulative probability (%) of cancer by age 40–50 y5 | 85 | 35 | 52 | 71 | 55 | 53 (by age 17) | 14 |
Projected median survival age5 | 23 | 45 | 39 | 35 | 50 | 16 | >70 |
% alive or dead ≥16 y of age | 27 | 58 | 22 | 22 | 32 | 5 | 16 |
Genetics | AR, XLR | XLR, AD, AR | AD | AR | AD, AR | AR | AR? |
Genes6 | >13 | >3 | >2 | >1? | >3 | 1 | ? |
Feature . | Fanconi anemia . | Dyskeratosis congenita . | Diamond-Blackfan anemia . | Shwachman-Diamond syndrome . | Severe congenital neutropenia2 . | Amegakaryocytic thrombocytopenia . | Thrombocytopenia absent radii . |
---|---|---|---|---|---|---|---|
Abbreviations: AR, autosomal recessive; XLR, X-linked recessive; AD, autosomal dominant; MDS, myelodysplastic syndrome; HNSCC, head and neck squamous cell carcinoma; Gyn, gynecological. | |||||||
?, data not available or unclear. Cancer means leukemia or solid tumor, probability assuming no other adverse event occurs. | |||||||
1Data derived from cases reported in the literature. | |||||||
2Rosenberg et al5 | |||||||
3Age at hematologic diagnosis in most cases, except in SCN, where it is the age of starting treatment with granulocyte colony-stimulating factor (G-CSF). | |||||||
4Physical findings are outlined in Table 2. | |||||||
5Kaplan-Meier survival analysis, censored at death. | |||||||
6Genes are described in Table 3. | |||||||
~N Lit Cases | >1850 | 425 | 825 | 500 | 374 | 100 | 280 |
Male:Female | 1.2:1 | 4:1 | 1.1:1 | 1.5:1 | 1.2 | 0.8:1 | 0.7:1 |
Age at diagnosis, median (range)3 | 6.6 (0–49) | 15 (0–75) | 0.25 (0–64) | 1 (0–41) | 3 (0–70)2 | 0.1 (0–11) | 0–0.6 |
% diagnosed ≥16 y of age2 | 9 | 46 | 1 | 5 | 132 | 0 | 0 |
Physical findings4 | Yes | Yes | Yes | Yes | No | No | Yes |
Usual hematology | Pancytopenia | Pancytopenia | Anemia | Neutropenia | Neutropenia | Thrombocytopenia | Thrombocytopenia |
Aplastic anemia | Yes | Yes | Rare | Yes | No | Yes | No |
Screening test | Chromosome breakage | Telomere length | Adenosine deaminase | Pancreatic insufficiency | Promyelocyte arrest | Absent/abnormal megakaryocytes | Absent megakaryocytes |
Leukemia or MDS | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Solid tumors | HNSCC, Gyn, brain | HNSCC | Osteosarcoma | No | No | No | No |
Age at cancer, median (range) | 15 (0.1–48) | 28 (1.5–68) | 23 (1.2–44) | 18 (2–43) | 14 (2–26) | 12 (1.6–17) | 5.3 (0–67) |
Cumulative probability (%) of cancer by age 40–50 y5 | 85 | 35 | 52 | 71 | 55 | 53 (by age 17) | 14 |
Projected median survival age5 | 23 | 45 | 39 | 35 | 50 | 16 | >70 |
% alive or dead ≥16 y of age | 27 | 58 | 22 | 22 | 32 | 5 | 16 |
Genetics | AR, XLR | XLR, AD, AR | AD | AR | AD, AR | AR | AR? |
Genes6 | >13 | >3 | >2 | >1? | >3 | 1 | ? |